Zurich Cantonal Bank’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,291
| Closed | -$242K | – | 2908 |
|
|
2022
Q4 | $242K | Sell |
7,291
-10,438
| -59% | -$336K | ﹤0.01% | 1714 |
|
|
2022
Q3 | $559K | Buy |
17,729
+11,754
| +197% | +$381K | ﹤0.01% | 1123 |
|
|
2022
Q2 | $182K | Hold |
5,975
| – | – | ﹤0.01% | 1854 |
|
|
2022
Q1 | $155K | Hold |
5,975
| – | – | ﹤0.01% | 2055 |
|
|
2021
Q4 | $122K | Hold |
5,975
| – | – | ﹤0.01% | 2403 |
|
|
2021
Q3 | $115K | Sell |
5,975
-11,435
| -66% | -$228K | ﹤0.01% | 2265 |
|
|
2021
Q2 | $386K | Buy |
17,410
+6,477
| +59% | +$137K | ﹤0.01% | 1380 |
|
|
2021
Q1 | $287K | Buy |
10,933
+4,140
| +61% | +$98.4K | ﹤0.01% | 1568 |
|
|
2020
Q4 | $127K | Hold |
6,793
| – | – | ﹤0.01% | 2107 |
|
|
2020
Q3 | $115K | Hold |
6,793
| – | – | ﹤0.01% | 1921 |
|
|
2020
Q2 | $158K | Buy |
6,793
+3,291
| +94% | +$47.7K | ﹤0.01% | 1680 |
|
|
2020
Q1 | $29K | Hold |
3,502
| – | – | ﹤0.01% | 2213 |
|
|
2019
Q4 | $34K | Hold |
3,502
| – | – | ﹤0.01% | 2336 |
|
|
2019
Q3 | $33K | Hold |
3,502
| – | – | ﹤0.01% | 2277 |
|
|
2019
Q2 | $42K | Hold |
3,502
| – | – | ﹤0.01% | 2173 |
|
|
2019
Q1 | $62K | Hold |
3,502
| – | – | ﹤0.01% | 1874 |
|
|
2018
Q4 | $61K | Hold |
3,502
| – | – | ﹤0.01% | 1916 |
|
|
2018
Q3 | $52K | Hold |
3,502
| – | – | ﹤0.01% | 2138 |
|
|
2018
Q2 | $56K | Hold |
3,502
| – | – | ﹤0.01% | 2060 |
|
|
2018
Q1 | $50K | Buy |
3,502
+2,035
| +139% | +$30.1K | ﹤0.01% | 2080 |
|
|
2017
Q4 | $21K | Hold |
1,467
| – | – | ﹤0.01% | 2398 |
|
|
2017
Q3 | $21K | Hold |
1,467
| – | – | ﹤0.01% | 2252 |
|
|
2017
Q2 | $23K | Hold |
1,467
| – | – | ﹤0.01% | 2204 |
|
|
2017
Q1 | $20K | Hold |
1,467
| – | – | ﹤0.01% | 2308 |
|
|
2016
Q4 | $26K | Hold |
1,467
| – | – | ﹤0.01% | 2162 |
|
|
2016
Q3 | $28K | Buy |
1,467
+308
| +27% | +$6.03K | ﹤0.01% | 2072 |
|
|
2016
Q2 | $23K | Hold |
1,159
| – | – | ﹤0.01% | 2002 |
|
|
2016
Q1 | $24K | Hold |
1,159
| – | – | ﹤0.01% | 1919 |
|
|
2015
Q4 | $24K | Buy |
1,159
+535
| +86% | +$10.3K | ﹤0.01% | 1922 |
|
|
2015
Q3 | $11K | Buy |
624
+317
| +103% | +$5.79K | ﹤0.01% | 1932 |
|
|
2015
Q2 | $6K | Hold |
307
| – | – | ﹤0.01% | 1830 |
|
|
2015
Q1 | $6K | Buy |
+307
| New | +$5.68K | ﹤0.01% | 1789 |
|
Other funds holding VIVO
Zurich Cantonal Bank's VIVO Position: Q1 2023 in Review
Zurich Cantonal Bank sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 7,291 shares — an estimated $242K sold.
Zurich Cantonal Bank first reported a position in VIVO in Q1 2015 and held it in 32 quarters. The position peaked at $559K in Q3 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Zurich Cantonal Bank reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Zurich Cantonal Bank sold 7,291 Meridian Bioscience Inc shares in Q1 2023, an estimated $242K.
- Zurich Cantonal Bank first reported a position in Meridian Bioscience Inc in Q1 2015 and held it in 32 quarters.
- Zurich Cantonal Bank's Meridian Bioscience Inc position peaked at $559K in Q3 2022.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Zurich Cantonal Bank's 13F filing for Q1 2023, filed 8 May 2023.